BICX — Biocorrx Cashflow Statement
0.000.00%
Last trade - 00:00- $11.01m
- $17.55m
- $0.80m
Annual cashflow statement for Biocorrx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.21 | -4.38 | -3.77 | -5.21 | -3.51 |
| Depreciation | |||||
| Non-Cash Items | 0.905 | 1.73 | 1.18 | 2.56 | 1.68 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.704 | 0.578 | 0.714 | 1.52 | -0.515 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.54 | -2.04 | -1.85 | -1.1 | -2.3 |
| Capital Expenditures | -0.05 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.05 | 0 | — | — | — |
| Financing Cash Flow Items | 2.25 | -0 | -0.001 | -0.001 | 1.88 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.08 | 2.02 | 1.85 | 1.12 | 2.35 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.506 | -0.017 | -0.003 | 0.023 | 0.051 |